Logo

NIH

LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program

The project, funded by NIH and the Louisiana Department of Health, aims to sequence SARS-CoV-2 samples from a range of different patients.

NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations

The consortium aims to develop and evaluate methods for calculating polygenic risk scores for specific diseases, particularly for people of different ancestries.

NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity

The contracts are for two lateral flow rapid antigen tests, a laboratory-based test to detect and identify SARS-CoV-2 variants, and a rapid RT-PCR test.

Armonica Technologies Wins $349K SBIR Grant From NHGRI

he funding will help support product development of a nanopore sequencing-based method of direct DNA analysis, including epigenetic modifications.

SARS-CoV-2 Study Implicates Saliva in Viral Transmission

Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site.

Mar 2, 2021

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

Feb 23, 2021

Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development

Feb 17, 2021

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing
Premium

Feb 5, 2021

Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent

Feb 4, 2021

Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing
Premium

Feb 3, 2021

Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production

Jan 7, 2021

Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent

Dec 28, 2020

President Trump Signs FY 2021 Spending Bill to Boost NIH Budget 3 Percent

Dec 22, 2020

Congress Approves 3 Percent Increase in NIH Budget for Fiscal 2021

Dec 16, 2020

Meridian Bioscience Receives $1M NIH Grant for SARS-CoV-2 Test Launch

Dec 10, 2020

All of Us Program Returns First Genetic Results; Health-Related Finding to Follow in Late 2021
Premium

Dec 9, 2020

Day Zero Diagnostics Wins $300K NIH Grant to Refine HAI Outbreak Analysis Service

Nov 5, 2020

Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing

Oct 29, 2020

Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

Oct 16, 2020

NIH Kicks Off Second Stage of 4D Nucleome Program With $142M in Research Grants

Oct 6, 2020

RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing

Oct 6, 2020

Startup Coral Genomics Wins $2M SBIR Grant From NIH

Oct 1, 2020

DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development

Sep 29, 2020

Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

Sep 9, 2020

Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine
Premium

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.